NV Insights as we enter 2026

With 2026 around the corner, we’re naturally reflecting on the last 12 months at NV.

We operate across recruitment as well as providing funding support for founders, and each area of our business has experienced different trends.

On the recruitment side, for NV Talent we’ve seen an increase in individual candidates putting themselves forward, greater specialism and of course, like everyone else, navigating AI.We’ve found a balance in using AI where it makes sense, but our strength has remained in our emotional intelligence, existing networks and great relationships. When clients have asked for specialist candidates, we’ve successfully matched talented individuals based on intel that goes way beyond filters and keywords. Understanding and knowing our networks personally, down to their lifestyle, personalities and ambitions has been more relevant this year than ever.For NV Invest, we’re excited for the year ahead.

With an abundance of caution in the market in 2025, 2026 looks set to be primed for capital deployment and better deal flow, particularly across diagnostics, next generation sequencing and personalised medicine.Those of us working in the life sciences sector will know that it’s been a rollercoaster for the past few years, but the Government’s commitment to add investment into innovation, as well as opening up international reliance routes are all adding to the bigger picture for growth in 2026.

We’re looking forward to the new year and our diaries are open, so whether you’d like a reflection chat with people who truly understand your journey, or you’d rather focus on the future, we’d love to speak with you!